The first EDUFLUVAC workshop on immunoassay standardisation for universal flu vaccines took place on 18-19 June 2015 at the National Institute for Biological Standards and Control (NIBSC), UK. This workshop was co-organised and co-sponsored by the National Institute of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID), USA.
BELLEROPHON would like to make a call for the process development and production in E. coli according to Good Manufacturing Practice (GMP) of a protein vaccine candidate to be used in toxicological and phase I studies. The subcontracting is expected in Q4 2015.
The annual meeting of MVVC / MVVC 2 held in Oxford in March is mentioned in the EDCTP May news letter (page 6). Field trials of a new combination malaria vaccine, which are an integral part of the MVVC2 project, are funded by among others EDCTP.
Want to learn more about what EVI is doing, then join us for the 2015 Rendez-Vous on 9 December.
It is an increasing popular event, bringing together people from all corners of the scientific community, the European Commission and other like funders.
The results of JAIVAC phase I clinical trial of a recombinant blood stage vaccine candidate for plasmodium falciparum malaria based on MSP1 and EBA175 were published in PLOS one in April 2015.
This project was supported financially by the Department of Biotechnology and Irish Aid.
Vaccine Management Assistant - new deadline 5 June 2015 17:00 CET. Download PDF-version
An eighteen month junior position for a motivated individual for a phase I vaccine clinical trial.
Project Manager - deadline 15 June 2015 17:00 CET. Download PDF-version
A three year junior position to work with international partners.
EVI would like to thank all those who applied for these positions, and for their interest in EVI.
‘European Vaccine Initiative urges to sustain funding and political commitment to ensure continued success in combatting malaria’.
European Research Infrastructures for Poverty Related Diseases (EURIPRED)
News letter April 2015
Call for application for Free Services. Deadline: 12 May 2015
The MultiMalVax consortium will meet for the fourth time during the next annual meeting on 17-18 November 2015. The meeting will be hosted by GlaxoSmithKline, Belgium. Project progress and future activities will be discussed.
- 1 of 18